Seeking Alpha

Nektar Therapeutics (NKTR): Q1 EPS of -$0.36 misses by $0.03. Revenue of $17.9M (+58% Y/Y). (PR)

Nektar Therapeutics (NKTR): Q1 EPS of -$0.36 misses by $0.03. Revenue of $17.9M (+58% Y/Y). (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)